U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938854) titled 'Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries' on April 07.
Brief Summary: Disrupt PAD Japan is a prospective, multi-center, single-arm study of SWM-831 to treat moderate and severely calcified femoropopliteal arteries, prior to DCB or stenting.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Peripheral Arterial Disease
Intervention:
DEVICE: Peripheral Intravascular Lithotripsy (IVL)
For the Disrupt PAD Japan study, the Shockwave Medical Peripheral IVL System (SWM-831) is intended for lithotripsy enhanced balloon dilatation of lesions, including calcified ...